Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps.

Yoshimasa Imoto | Atsushi Kato | Tetsuji Takabayashi | Whitney Stevens | James E Norton | Lydia A Suh | Roderick G Carter | Ava R Weibman | Kathryn E Hulse | Kathleen E Harris | Anju T Peters | Leslie C Grammer | Bruce K Tan | Kevin Welch | Stephanie Shintani-Smith | David B Conley | Robert C Kern | Shigeharu Fujieda | Robert P Schleimer
The Journal of allergy and clinical immunology | 2019

Chronic rhinosinusitis (CRS) is a heterogeneous chronic inflammatory disease subdivided based on the presence or absence of nasal polyps (NPs). Histologic features of chronic rhinosinusitis with nasal polyps (CRSwNP) include inflammatory cell infiltration and excessive fibrin deposition in NPs. Thrombin-activatable fibrinolysis inhibitor (TAFI) is an enzyme that plays an antifibrinolytic role in the body. The significance of TAFI has been documented in patients with chronic inflammatory diseases, including chronic lung disease; however, it has not been evaluated in the pathogenesis of NPs.

Pubmed ID: 31562871

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: P01 AI145818
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI137174
  • Agency: NHLBI NIH HHS, United States
    Id: R37 HL068546
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI106683

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Bethyl (tool)

RRID:SCR_013554

An Antibody supplier

View all literature mentions